We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

FDA Announces Major Proposed Rule Amending Hatch-Waxman Regulations

13 February 2015

Pharmaceutical and Biotechnology Alert

On February 6, 2015, the Food and Drug Administration (FDA) published in the Federal Register (FR) a comprehensive proposed rule (80 FR 6802) to amend agency regulations governing Abbreviated New Drug Applications (ANDAs) and 505(b)(2) New Drug Applications (505(b)(2) NDAs) and the patent listing and certification provisions fundamental to the operation of the Drug Price Competition and Patent Restoration Act of 1984 (the Hatch-Waxman Act).

Read more: FDA Announces Major Proposed Rule Amending Hatch-Waxman Regulations

The team

Loading data